The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study on deep vein thrombosis (DVT) risk factors at the time of cancer diagnosis in patients from the multicenter, prospective Cancer-Venous Thromboembolism (VTE) Registry.
 
Yasuo Ohashi
Leadership - EP-Cruse Co., Ltd; EP-Techno; Statcom
Stock and Other Ownership Interests - Statcom
Honoraria - Chugai Pharma; Daiichi Sankyo; Kowa; Sanofi; Shionogi
Research Funding - Medical Members System (Inst)
 
Masataka Ikeda
Consulting or Advisory Role - Daiichi Sankyo
Speakers' Bureau - Bayer; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Pfizer; Taiho Pharmaceutical
 
Hideo Kunitoh
Honoraria - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Covidien; Daiichi Sankyo; EA Pharma; Eisai; Johnson & Johnson; Kyowa Hakko Kirin; MSD; Pfizer; Taiho Pharmaceutical
 
Mitsuru Sasako
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Lilly Japan; Merck; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Olympus
 
Takuji Okusaka
Honoraria - Abbvie; AstraZeneca; Bayer; Celgene; Daiichi Sankyo; EA pharma; Eisai; Fujifilm; Lilly; Meiji Seika Kaisha; MSD; Mundipharma; Nippon Shinyaku; Novartis; Ono Pharmaceutical; Pfizer; SERVIER; Shire; Taiho Pharmaceutical; Takeda; Teijin Pharma; Yakult Honsha
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Dainippon Sumitomo Pharma; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Baxter (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Takara Bio
 
Hirofumi Mukai
Honoraria - Daiichi Sankyo; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Daiichi Sankyo (Inst)
 
Keiichi Fujiwara
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen Oncology; Kyowa Hakko Kirin; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; Genmab; MSD; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); Genmab (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Regeneron (Inst); Shionogi (Inst); Zeria Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; MSD; Pfizer
 
Mashio Nakamura
Honoraria - Daiichi Sankyo
Consulting or Advisory Role - Daiichi Sankyo
 
Mari Saito-Oba
Consulting or Advisory Role - Daiichi Sankyo (Inst)
 
Tetsuya Kimura
Employment - Daiichi Sankyo
 
Kei Ibusuki
Employment - Daiichi Sankyo
 
Masato Sakon
Honoraria - Daiichi Sankyo
Consulting or Advisory Role - Daiichi Sankyo